Rongchang Biology

Rongchang Biological Clinical Research appeared in international journals for the treatment of refractory pediatric systemic lupus erythematosus
Systemic lupus erythematosus in children clinic Rongchang Biology Systemic lupus erythematosus Children's Hospital affiliated to Fudan University Autoimmune diseases
05-09
Mixed feelings? Take stock of the commercialization progress of the first batch of new drugs in the world in 2021
Agironse injection Vidicetizumab Les Pran Fosun Kate Fosun Pharma Corning Jerry Pharmaceuticals Tengsheng Bo medicine Elise Pharma Rongchang Biology nmpa
04-25
Rongchang Biotech Was Listed on the Science and Technology Innovation Board, and two new drug products have been commercialized
Rongchang Biology Science and Technology Innovation Board
04-01
The HPV vaccine will be free throughout the country; the presidents of tertiary hospitals will go down to the grass-roots level; and the management of radioactive drugs will be strengthened
National Health Commission hpv vaccine Jiuan Medical Rongchang Biology
01-17
China's first ADC for the treatment of urinary urothelial cancer is coming! Rongchang Bio vidicetizumab new indications were approved for listing
Vidicetizumab Urinary tract carcinoma Rongchang Biology State Food and Drug Administration of China her2
01-06
The new version of the medical insurance directory is implemented! Rongchang Bio Tai Ai and Edich issued the first medical insurance prescription
Vidicetizumab Rongchang Biology Edich Tai Ai Systemic lupus erythematosus Tatta Sip
01-05
In 2021, more than 30 new drugs will be listed through priority review, and oncology drugs will still be the main line of domestic innovation
Tumor drugs Vidicetizumab drugs Rongchang Biology tumor
12-30